Skip to main content

Publications

14 publications

Clinical research

4 studies

Active

2 studies
  • PI
    Prevalence of headache as a chief complaint in pediatric patients with brain tumors: a retrospective chart review
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
  • PI
    Phase 3, Multicenter, Randomized, Double-blind, Group Sequential, Placebo-controlled Study to Assess Efficacy and Safety of Rimegepant for the Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 to < 18 Years of Age
    PHASE3 · Pfizer, Inc. · OPEN TO ACCRUAL (as of 2024)
    Pediatric Migraine
    NCT04649242
Completed & closed trials (2)
  • PI
    Prospective, Retrospective, Multicenter, Observational Study of Disease Progression in Adults With Inherited Forms of Spastic Paraplegia
    SwanBio Therapeutics Limited · IRB STUDY CLOSURE (as of 2025)
    AMN; AMN Gene Mutation; X-ALD
    NCT05008874
  • PI
    A Phase 1/2 Open-Label Study of the Safety and Clinical Activity of Gene Therapy for Canavan Disease Through Administration of an Adeno-Associated Virus (AAV) Serotype 9-Based Recombinant Vector Encoding the Human ASPA Gene
    PHASE1; PHASE2 · Aspa Therapeutics, Inc. · IRB STUDY CLOSURE (as of 2024)
    Canavan Disease
    NCT04998396